J. K. Dart, V. P. Saw, and S. Kilvington, Acanthamoeba keratitis: diagnosis and treatment update, Am J Ophthalmol, vol.148, pp.487-99, 2009.

M. J. Elder, S. Kilvington, and J. K. Dart, A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis, Invest Ophthalmol Vis Sci, vol.35, pp.1059-64, 1994.

A. M. Cabello-vilchez, C. M. Martín-navarro, and A. López-arencibia, Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru, Parasitol Res, vol.113, pp.755-764, 2014.

S. Bang, E. Edell, and A. O. Eghrari, Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis, Am J Ophthalmol, vol.149, pp.66-75, 2010.

E. Y. Tu, C. E. Joslin, and M. E. Shoff, Successful treatment of chronic stromal Acanthamoeba keratitis with oral voriconazole monotherapy, Cornea, vol.29, pp.1066-1074, 2010.

D. E. Sykes and R. N. Band, Polyphenol oxidase produced during encystation of Acanthamoeba castellanii, J Protozool, vol.32, pp.512-519, 1985.

C. Vasseneix, G. Gargala, and A. François, A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents, Cornea, vol.25, pp.597-602, 2006.

Z. A. Polat, J. Walochnik, and A. Obwaller, Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis, Clin Exp Ophthalmol, vol.42, pp.151-159, 2014.

T. J. Ruddell and D. L. Easty, Drug therapy in a murine model of Acanthamoeba keratitis, Eye, vol.9, pp.142-145, 1995.

Y. Qvarnstrom, G. S. Visvesvara, and R. Sriram, Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri, J Clin Microbiol, vol.44, pp.3589-95, 2006.

M. Cahane, S. Ben, and I. S. Barequet, Human corneal stromal tissue concentration after consecutive doses of topically applied 3.3% vancomycin, Br J Ophthalmol, vol.88, pp.22-26, 2004.

P. Rocha-cabrera, M. Reyes-batlle, and C. M. Martín-navarro, Detection of Acanthamoeba on the ocular surface in a Spanish population using the Schirmer strip test: pathogenic potential, molecular classification and evaluation of the sensitivity to chlorhexidine and voriconazole of the isolated Acanthamoeba strains, J Med Microbiol, vol.64, pp.849-53, 2015.

F. L. Schuster, B. J. Guglielmo, and G. S. Visvesvara, In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri, J Eukaryot Microbiol, vol.53, pp.121-127, 2006.

A. Sunada, K. Kimura, and I. Nishi, In vitro evaluations of topical agents to treat Acanthamoeba keratitis, Ophthalmology, vol.121, pp.2059-65, 2014.

C. M. Martín-navarro, A. López-arencibia, and F. Arnalich-montiel, Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba, Graefes Arch Clin Exp Ophthalmol, vol.251, pp.2111-2118, 2013.

A. Iovieno, D. Miller, and D. R. Ledee, Cysticidal activity of antifungals against different genotypes of Acanthamoeba, Antimicrob Agents Chemother, vol.58, pp.5626-5634, 2014.

C. F. Neoh, L. Leung, and C. E. , Open-label study of absorption and clearance of 1% voriconazole eye drops, Antimicrob Agents Chemother, vol.60, pp.6896-6904, 2016.

W. Sponsel, N. Chen, and D. Dang, Topical voriconazole as a novel treatment for fungal keratitis, Antimicrob Agents Chemother, vol.50, pp.262-270, 2006.

G. A. Vemulakonda, S. M. Hariprasad, and W. F. Mieler, Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans, Arch Ophthalmol, vol.126, pp.18-22, 2008.

A. B. Clode, J. L. Davis, and J. Salmon, Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses, Am J Vet Res, vol.67, pp.296-301, 2006.

M. J. Dolton, G. Mikus, and J. Weiss, Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing, J Antimicrob Chemother, vol.69, pp.1633-1674, 2014.

S. M. Hariprasad, W. F. Mieler, and E. R. Holz, Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans, Arch Ophthalmol, vol.122, pp.42-49, 2004.